We are live on
!
Find out more
enGene Therapeutics
ENGN
ENGN
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
FIS
1
FCPM III Services
Naarden,
Netherlands
| $80.1M | +$76.8M | +8,677,951 | New |
|
|
BI
2
BVF Inc
San Francisco,
California
| $20.8M | +$19.9M | +2,251,037 | New |
|
|
BOCH
3
Blue Owl Capital Holdings
New York
| $11.4M | +$10.9M | +1,234,760 | New |
|
|
OFM
4
Omega Fund Management
Boston,
Massachusetts
| $10.4M | +$10M | +1,131,175 | New |
|
|
VC
5
Vivo Capital
Palo Alto,
California
| $6.26M | +$6.01M | +678,705 | New |
|
|
PAMP
6
Polar Asset Management Partners
Toronto,
Ontario, Canada
| $1.07M | +$1.03M | +116,942 | New |
|
7
Royal Bank of Canada
Toronto,
Ontario, Canada
| $349K | +$335K | +37,845 | New |
|
8
Goldman Sachs
New York
| $346K | +$331K | +37,447 | New |
|
9
Citadel Advisors
Miami,
Florida
| $185K | +$177K | +20,057 | New |
|
10
UBS Group
Zurich,
Switzerland
| $17.9K | +$17.1K | +1,937 | New |
|
11
Morgan Stanley
New York
| $74 | +$71 | +8 | New |
|